Search clinical trials for: Dupilumab SAR231893
Total 208 results
-
Regeneron PharmaceuticalsSanofiCompletedAtopic DermatitisGermany, Poland, United Kingdom, Hungary, Canada, Czechia
-
Regeneron PharmaceuticalsAvailableBullous Pemphigoid | Pediatric Asthma | Pediatric Eosinophilic Esophagitis (EoE) | Pediatric and Adolescent Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)
-
Regeneron PharmaceuticalsSanofiActive, not recruitingAtopic DermatitisUnited States, Canada, Czechia, Germany, Hungary, Poland, United Kingdom
-
Regeneron PharmaceuticalsSanofiCompletedAtopic DermatitisPoland, Germany, France, Hungary, Czechia
-
Regeneron PharmaceuticalsSanofiCompletedAtopic DermatitisUnited States, Germany, Poland, Japan, Canada, Hungary, Czechia
-
SanofiRegeneron PharmaceuticalsRecruiting
-
Regeneron PharmaceuticalsSanofiCompleted
-
Regeneron PharmaceuticalsSanofiActive, not recruitingEosinophilic Esophagitis (EoE)United States, Canada
-
Regeneron PharmaceuticalsSanofiRecruitingChronic Rhinosinusitis With Nasal PolyposisUnited States, Italy, Canada, Japan, Germany, Netherlands
-
Regeneron PharmaceuticalsSanofiActive, not recruitingAsthmaUnited States, United Kingdom, Canada, France, Puerto Rico, Japan, Spain, Denmark, Italy, Sweden
-
Regeneron PharmaceuticalsSanofiCompletedPeanut AllergyUnited States, Canada
-
Regeneron PharmaceuticalsSanofiCompletedAllergic Bronchopulmonary AspergillosisUnited States, Hungary, Bulgaria, France, Germany, Japan, Netherlands, Poland, Romania, United Kingdom
-
Regeneron PharmaceuticalsSanofiCompletedAtopic DermatitisHungary, Netherlands, Spain, United Kingdom, United States, Australia, Austria, Belgium, Bulgaria, Canada, China, Czechia, Denmark, Estonia, Finland, France, Germany, Ireland, Italy, Japan, Korea, Republic of, Lithuania, New Zealand, ... and more
-
Regeneron PharmaceuticalsSanofiAvailableBullous Pemphigoid
-
Regeneron PharmaceuticalsSanofiCompletedConjunctivitis | Atopic DermatitisUnited States
-
Regeneron PharmaceuticalsCompletedAsthmaUnited States, Spain, France, Germany, Poland
-
SanofiRegeneron PharmaceuticalsCompletedChronic Sinusitis | Sinusitis | Chronic Rhinosinusitis Without Nasal Polyps | Sinus Disorder | Respiratory DisorderBelgium, Spain, Argentina, Ukraine, Portugal, China, United States, Canada, Chile, Hungary, Korea, Republic of, Russian Federation, Sweden
-
SanofiRegeneron PharmaceuticalsCompleted
-
SanofiRegeneron PharmaceuticalsCompleted
-
Regeneron PharmaceuticalsSanofiRecruitingAtopic Dermatitis | Adverse Pregnancy OutcomesUnited States
-
Regeneron PharmaceuticalsSanofiRecruitingAsthma | Atopic Dermatitis (AD)United States
-
SanofiRegeneron PharmaceuticalsActive, not recruitingAsthmaPortugal, Ukraine, Spain, Taiwan, Sweden, United States, Bulgaria, Denmark, France, Italy, Romania, Saudi Arabia, United Kingdom
-
SanofiRegeneron PharmaceuticalsActive, not recruitingAllergic Fungal RhinosinusitisChina, Argentina, Israel, United States, Canada, India, Japan, Saudi Arabia, Turkey
-
SanofiRegeneron PharmaceuticalsCompletedDermatitis AtopicUnited States, United Kingdom
-
SanofiRegeneron PharmaceuticalsCompletedHealthy VolunteersUnited States
-
SanofiRegeneron PharmaceuticalsCompletedDermatitis AtopicUnited States, Germany
-
SanofiRegeneron PharmaceuticalsCompletedAtopic DermatitisUnited States, Canada
-
SanofiRegeneron PharmaceuticalsCompletedAsthmaSpain, Canada, Denmark, Belgium, Japan, Korea, Republic of, Mexico, United States, Israel, Brazil, Australia, France, Germany, United Kingdom, Argentina, Chile, Colombia, Hungary, Italy, Netherlands, Poland, Romania, Russian Federation and more
-
SanofiRegeneron PharmaceuticalsNot yet recruiting
-
SanofiRegeneron PharmaceuticalsRecruitingPrurigo NodularisUnited States
-
SanofiRegeneron PharmaceuticalsRecruitingAsthmaIsrael, Argentina, Chile, Colombia, Kuwait, Lebanon, Mexico, Qatar, Russian Federation, Saudi Arabia, Singapore, United Arab Emirates
-
SanofiRegeneron PharmaceuticalsCompletedChronic Rhinosinusitis With Nasal PolypsJapan
-
SanofiRegeneron PharmaceuticalsCompletedAtopic DermatitisFrance, United States, Australia, Germany, Israel, Italy, Spain, Switzerland, United Arab Emirates, United Kingdom
-
Regeneron PharmaceuticalsSanofiCompletedAtopic DermatitisUnited States
-
SanofiRegeneron PharmaceuticalsActive, not recruitingDermatitis AtopicSpain, Czechia, Italy, Israel, Argentina, Australia, Austria, Belgium, Colombia, Finland, France, Greece, Japan, Kuwait, Mexico, Netherlands, Norway, Portugal, Russian Federation, Saudi Arabia, Taiwan, United Arab Emirates
-
SanofiRegeneron PharmaceuticalsRecruitingAsthma | WheezingCanada, United States, Argentina, Brazil
-
Regeneron PharmaceuticalsSanofiCompletedEosinophilic EsophagitisUnited States, Australia, Belgium, Canada, France, Germany, Italy, Netherlands, Spain, Sweden, Switzerland, United Kingdom
-
Regeneron PharmaceuticalsSanofiCompletedDermatitis, AtopicUnited States, France, Poland, United Kingdom, Germany, Hong Kong, Canada, Korea, Republic of, Italy, Lithuania, Sweden
-
Regeneron PharmaceuticalsSanofiCompletedModerate to Severe Atopic Hand and Foot DermatitisUnited States, Germany, Japan, Poland
-
SanofiRegeneron PharmaceuticalsCompletedAsthmaUnited States, Argentina, Belgium, Canada, France, Germany, Israel, Japan, Netherlands, South Africa
-
Regeneron PharmaceuticalsSanofiCompletedEosinophilic EsophagitisUnited States
-
Regeneron PharmaceuticalsSanofiCompletedDermatitis, AtopicUnited States, Germany, Poland, United Kingdom
-
Regeneron PharmaceuticalsSanofiCompletedAtopic DermatitisGermany, New Zealand, Australia
-
Regeneron PharmaceuticalsSanofiCompletedDermatitis, AtopicUnited States, Germany, Spain, Bulgaria, Japan, Canada, Denmark, Finland, Singapore, Estonia
-
SanofiRegeneron PharmaceuticalsCompleted
-
Regeneron PharmaceuticalsSanofiCompletedStudy to Determine the Safety and Effectiveness of Dupilumab for Treatment of Atopic Dermatitis (AD)Atopic Dermatitis (AD)United States, Canada
-
SanofiRegeneron PharmaceuticalsCompletedAtopic DermatitisChina
-
Regeneron PharmaceuticalsSanofiRecruitingModerate-to-Severe Atopic Dermatitis | Atopic EczemaUnited States